Spots Global Cancer Trial Database for renal pelvis cancer
Every month we try and update this database with for renal pelvis cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Urine DNA Methylation Detection for Hematuria Evaluation | NCT06427993 | Hematuria Urothelial Carc... Bladder Cancer Ureter Cancer Renal Pelvis Ca... | 18 Years - 99 Years | Changhai Hospital | ||
| Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors | NCT03662204 | Breast Cancer Lung Cancer Colorectal Canc... Prostate Cancer Bladder Cancer Uterine Cancer Kidney Cancer Renal Pelvis Ca... Pancreatic Canc... Liver Cancer Stomach Cancer Ovarian Cancer Esophageal Canc... | Blood Sample Co... | 18 Years - | Exact Sciences Corporation | |
| Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors | NCT03662204 | Breast Cancer Lung Cancer Colorectal Canc... Prostate Cancer Bladder Cancer Uterine Cancer Kidney Cancer Renal Pelvis Ca... Pancreatic Canc... Liver Cancer Stomach Cancer Ovarian Cancer Esophageal Canc... | Blood Sample Co... | 18 Years - | Exact Sciences Corporation | |
| DN24-02 as Adjuvant Therapy in Subjects With High Risk HER2+ Urothelial Carcinoma | NCT01353222 | Urothelial Carc... | DN24-02 Standard of Car... | 18 Years - | Dendreon | |
| Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors | NCT03662204 | Breast Cancer Lung Cancer Colorectal Canc... Prostate Cancer Bladder Cancer Uterine Cancer Kidney Cancer Renal Pelvis Ca... Pancreatic Canc... Liver Cancer Stomach Cancer Ovarian Cancer Esophageal Canc... | Blood Sample Co... | 18 Years - | Exact Sciences Corporation | |
| Enzalutamide in Combination With Gemcitabine and Cisplatin in Bladder Cancer | NCT02300610 | Bladder Cancer Carcinoma, Tran... Renal Pelvis Ca... Ureter Cancer Urethra Cancer | Enzalutamide Cisplatin Gemcitabine | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Vaccine Therapy in Treating Patients With Transitional Cell Carcinomas | NCT00070070 | Transitional Ce... | TICE®-strain BC... NY-ESO-1 protei... sargramostim | 18 Years - | Ludwig Institute for Cancer Research | |
| A Genotype-Phenotype Urothelial Cancer Registry | NCT00902590 | Urothelial Canc... Renal Pelvis Ca... Ureter Cancer Bladder Cancer | saliva sample a... saliva sample, ... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| A Phase II Study of AZD4877 (a Novel Anti-mitotic Agent) in Advanced Bladder Cancer | NCT00661609 | Bladder Cancer Transitional Ce... Urethra Cancer Ureter Cancer Renal Pelvis Ca... | AZD4877 | 18 Years - | AstraZeneca | |
| A Genotype-Phenotype Urothelial Cancer Registry | NCT00902590 | Urothelial Canc... Renal Pelvis Ca... Ureter Cancer Bladder Cancer | saliva sample a... saliva sample, ... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Vaccine Therapy in Treating Patients With Transitional Cell Carcinomas | NCT00070070 | Transitional Ce... | TICE®-strain BC... NY-ESO-1 protei... sargramostim | 18 Years - | Ludwig Institute for Cancer Research | |
| Phase I Study With Sorafenib in Addition to Vinflunine in Metastatic Transitional Cell Carcinoma of the Urothelial Tract | NCT01844947 | Urothelial Carc... Bladder Cancer Renal Pelvis Ca... Ureter Cancer Urethra Cancer | Vinflunine Sorafenib | 18 Years - 80 Years | Karolinska University Hospital | |
| DN24-02 as Adjuvant Therapy in Subjects With High Risk HER2+ Urothelial Carcinoma | NCT01353222 | Urothelial Carc... | DN24-02 Standard of Car... | 18 Years - | Dendreon | |
| A Trial With Vinflunine in Patients With Metastatic Bladder Cancer and Impaired Renal Function | NCT02665039 | Urothelial Carc... Bladder Cancer Renal Pelvis Ca... Ureter Cancer Urethra Cancer | Vinflunine Gemcitabine Carboplatin | 18 Years - | Karolinska University Hospital | |
| A Phase I/II Trial of AEZS-108 in Urothelial Cancer Patients Who Failed Platinum-chemotherapy | NCT01234519 | Urothelial Carc... | AEZS-108 AEZS-108 at MTD | 18 Years - | AEterna Zentaris | |
| A Study of LOXO-435 in Participants With Cancer With a Change in a Gene Called FGFR3 | NCT05614739 | Urinary Bladder... Neoplasm Metast... Ureteral Neopla... | LOXO-435 Pembrolizumab | 18 Years - | Eli Lilly and Company | |
| A Trial With Vinflunine in Patients With Metastatic Bladder Cancer and Impaired Renal Function | NCT02665039 | Urothelial Carc... Bladder Cancer Renal Pelvis Ca... Ureter Cancer Urethra Cancer | Vinflunine Gemcitabine Carboplatin | 18 Years - | Karolinska University Hospital | |
| Cancer in Patients With Gabapentin (GPRD) | NCT01236053 | Pain, Neuropath... Epilepsy Renal Pelvis Ca... Pancreatic Canc... Breast Cancer Nervous System ... Chronic Pancrea... Stomach Cancer Renal Cell Carc... Diabetes Bladder Cancer Bone and Joint ... Penis Cancer Anal Cancer Cancer Renal Cancer | Gabapentin pres... | - | GlaxoSmithKline | |
| Enzalutamide in Combination With Gemcitabine and Cisplatin in Bladder Cancer | NCT02300610 | Bladder Cancer Carcinoma, Tran... Renal Pelvis Ca... Ureter Cancer Urethra Cancer | Enzalutamide Cisplatin Gemcitabine | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| A Study of LOXO-435 in Participants With Cancer With a Change in a Gene Called FGFR3 | NCT05614739 | Urinary Bladder... Neoplasm Metast... Ureteral Neopla... | LOXO-435 Pembrolizumab | 18 Years - | Eli Lilly and Company | |
| Gemcitabine and Split-Dose Cisplatin Plus Everolimus (RAD001) in Patients With Advanced Solid Tumor Malignancies | NCT01182168 | Bladder Cancer Renal Pelvis Ca... Ureter Cancer | gemcitabine and... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Avelumab in Combination With AVB-S6-500 in Patients With Advanced Urothelial Carcinoma | NCT04004442 | Urothelial Carc... | Avelumab AVB-S6-500 | 18 Years - | University of Oklahoma | |
| TRC105 in Adults With Advanced/Metastatic Urothelial Carcinoma | NCT01328574 | Urothelial Carc... Ureteral Neopla... Ureter Cancer Neoplasm, Urete... Cancer of the U... | TRC105 | 18 Years - 99 Years | National Institutes of Health Clinical Center (CC) |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
